1. IL-27 Alleviates Airway Inflammation and Airway Hyperresponsiveness in Asthmatic Mice by Targeting the CD39/ATP Axis of Dendritic Cells.
- Author
-
Chen Y, Zhu M, Hu J, He S, Li S, Liu B, and Yang J
- Subjects
- Animals, Mice, Inflammation metabolism, Inflammation immunology, Interleukins metabolism, Lung pathology, Lung metabolism, Lung immunology, Mice, Knockout, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, Ovalbumin toxicity, Receptors, Interleukin metabolism, Respiratory Hypersensitivity metabolism, Adenosine Triphosphate metabolism, Antigens, CD metabolism, Apyrase metabolism, Asthma immunology, Asthma metabolism, Asthma chemically induced, Dendritic Cells metabolism, Dendritic Cells immunology
- Abstract
Interleukin-27 receptor (IL-27R) is expressed in a variety of immune cells and structural cells, including dendritic cells. The mechanism of IL-27 in asthma has not been fully elucidated. This study aimed to examine whether IL-27 regulated the CD39/ATP axis of dendritic cells in asthma. Our results showed that in ovalbumin (OVA)-induced asthma mouse model, IL-27Rα
-/- asthmatic mice showed increased airway resistance, increased infiltration of inflammatory cells in lung tissue, proliferation of goblet cells, enhanced expression of Muc5 AC around airway epithelium, increased total number of cells and eosinophils, increased levels of total IgE, OVA-IgE, IL-4, IL-5, IL-13 and IL-17 A, and increased expression of transcription factors GATA-3 and RORγt in lung tissue. The expression of CD39 mRNA and protein in the lung tissue of IL-27Rα-/- asthmatic mice decreased, and the expression of NLRP3, ASC and Caspase-1 in NLRP3 inflammasome components increased. The concentration of ATP was significantly increased compared with WT asthmatic mice. In vitro experiments showed that the expression of CD39 in lung dendritic cells of IL-27Rα-/- asthmatic mice decreased, while the expression of NLRP3 inflammasome components NLRP3, ASC and Caspase-1 increased. These findings indicate that IL-27 directly and indirectly regulates immunoinflammatory responses in asthma by acting on dendritic cells CD39/ATP Axis., (© 2023. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF